抗感冒中成药药物经济学评价的文献研究

目的 了解抗感冒中成药药物经济学评价的研究现状，分析存在的问题并提出相关建议。方法 通过检索中国期刊全文数据库（CNKI）、中文科技期刊全文数据库（VIP）、万方数据库、Pubmed数据库，纳入从建库至2017年6月所有抗感冒中成药的药物经济学评价文献，将信息输入Microsoft Excel（2010版）软件进行系统分析与评估。结果 根据纳入与排除标准，共获取符合要求的文献21篇，结果发现存在研究角度不明确、回顾性研究居多、目标人群的纳入排除标准不严谨、研究时限偏短、分析技术不合理、模型应用少、成本测算不全面、产出指标未能体现中药特色、疗效判定不严谨等问题。结论 目前对抗感冒中成药药物经济学评价的探索相对较少，文献质量普遍偏低，研究方法尚待规范。

Literature Research of the Pharmacoeconomics Evaluation about Anti-cold Chinese Patent Medicine

Objective To investigate the current status of pharmacoeconomics evaluation about anti-cold Chinese Patent Medicine and analyze the existing problems and put forward related suggestions. Methods By searching CNKI, VIP, Wanfang database, and Pubmed database, pharmacoeconomics literatures about anti-cold Chinese Patent Medicine published from the database building to June 2017 were included. The information were input into Microsoft Excel (2010 version) for system analysis and evaluation. Results According to the inclusion and exclusion criteria, a total of 21 papers that meet the requirements were obtained. There are some problems found in these papers, in which the study perspective was not clear, mostly were retrospective studies, the inclusion and exclusion criteria of target population was not rigorous, the study time was short, the analysis technical was unreasonable, less model application, the cost was not comprehensive, the effect indicator failed to reflect the characteristics of TCM, and the curative effect judgment was loose. Conclusions At present, the research of pharmacoeconomics evaluation about anti-cold Chinese Patent Medicine is relatively few, the quality of such studies is generally low and the research methods have yet to be standardized.